Clinical Trials Browser

Phase 2 × OTHER_GOV × Carcinoma, Renal Cell × Clear all

NCT07470840 2026-03-17

SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma

Phase 2 Not yet recruiting

Carcinoma, Renal Cell

NCT02626754 2018-06-26

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Phase 2 Terminated

Carcinoma, Renal Cell

NCT01791387 2015-02-03

DILIGENCE-1

Phase 2 Unknown

Carcinoma, Carcinoma, Renal Cell, Neoplasms